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Background: Inflammatory bowel disease (IBD) has been associated with renal stone   formation. 
The objective of this study was to determine prospectively the prevalence of nephrolithiasis 
in a community-based population of patients with IBD and to analyze factors associated with 
renal calculus formation.
Methods: Screening renal ultrasound was performed in a well characterized cohort of patients 
seen between 2009 and 2012 at an IBD clinic. We enrolled 168 patients, including 93 with 
Crohn’s disease and 75 with ulcerative colitis. Clinical and phenotypic variables associated with 
asymptomatic nephrolithiasis were determined.
Results: Nephrolithiasis was detected in 36 patients with Crohn’s disease and in 28 patients with 
ulcerative colitis (38% for both). Although none of the patients had been previously hospitalized 
for symptomatic nephrolithiasis, nine with Crohn’s disease and five with ulcerative colitis had 
recurrent urinary tract infections or hydronephrosis. In patients with Crohn’s disease, ileocolonic 
(L3) disease was associated with a greater risk of nephrolithiasis than was ileal (L1) or colonic 
(L2) disease (odds ratio [OR] 2.3, 95% confidence interval [CI] 1.8–7). Active ulcerative colitis 
(regardless of severity) represented a significant risk factor for formation of renal calculi (OR 
4.2, 95% CI 1.1–15, P = 0.02).
Conclusion: In surgery-naïve patients with IBD in the community, asymptomatic nephrolithiasis 
is common and should be considered when renal dysfunction or infection is detected.
Keywords: clinical activity indices, Crohn’s disease, inflammatory bowel disease, nephro-
lithiasis, ulcerative colitis
Introduction
Nephrolithiasis represents a serious health problem in some countries. For instance, 
it has been reported that 5%–15% of the general population in the United States will 
develop renal calculi in their lifetime, with the five-year recurrence rate ranging from 
30% to 50%. Diet and gender are considered to be risk factors for the development of 
renal calculi, the incidence of which is higher in males. In the United States, nephro-
lithiasis accounts for 1% of all hospitalizations and is responsible for annual medical 
costs of two billion dollars.1–4
Chronic diseases that are accompanied by intermittent diarrhea, such as ulcerative 
colitis and Crohn’s disease, are directly associated with the formation of renal calculi. 
Historical studies have demonstrated that the prevalence of symptomatic nephrolithia-
sis is higher in patients with inflammatory bowel disease (IBD, 7%–15%) than in the 
general population (1%–15%), typically in patients who have undergone extensive 
small bowel resection or in those with persistent severe small bowel inflammation.5,6 
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Extensive small bowel resections can lead to steatorrhea and 
increase the risk of hyperoxaluria by 28%, because these 
interventions can lead to loss of the bacterium Oxalobacter 
formigenes or chelation of free calcium in the colonic lumen 
by lipids.7 In addition, it has been reported that patients who 
have an ostomy are more likely to develop uric acid stones 
than calcium oxalate stones.6,8,9
In the last 10 years, new therapeutic approaches to 
patients with IBD have emerged and completely changed 
the natural history of these diseases; the impact of such 
approaches is reflected not only in lower rates of surgery 
but also in better prognoses, fewer hospitalizations, and bet-
ter improved quality of life.9 Whether this has changed the 
prevalence of and risk factors for renal calculi in this patient 
population is unknown.
The objective of the present study was to determine pro-
spectively the prevalence of nephrolithiasis in a community-
based population of patients with IBD who had not undergone 
surgery. In addition, we sought to identify risk factors for 
formation of renal calculi in this population.
Materials and methods
We investigated a community-based population of patients 
with IBD treated between 2009 and 2012 at a clinic in the 
city of Campo Grande, located in the central-west region of 
Brazil. This was an analysis of prospectively collected data. 
Patients with ulcerative colitis were classified as having 
proctosigmoiditis, left-sided colitis, or pancolitis, whereas 
patients with Crohn’s disease were classified in accordance 
with the Vienna classification of Crohn’s disease. We deter-
mined disease activity using the Truelove–Witts index for 
patients with ulcerative colitis and the Crohn’s Disease 
Activity Index for patients with Crohn’s disease at the time 
of the index visit.
At the first appointment with the gastroenterologist, an 
ultrasound of the kidneys and urinary tract was requested in 
order to screen for renal calculi, as is the clinical practice 
of the treating physician (DC). On the basis of the results, 
all patients with calculi or hydronephrosis were referred to 
a nephrologist for follow-up evaluation. We analyzed the 
electronic medical records of 168 patients monitored during 
the 12-month study period. The study was approved by the 
Universidade de São Paulo ethics committee (182330).
Statistical analysis
Continuous variables are presented as the mean and standard 
deviation, and categorical variables are presented as percent-
ages. We used the Student’s t-test to analyze continuous 
variables, and used the chi-square test or Fisher’s exact test to 
analyze categorical variables. Odds ratios were calculated 
using 2 × 2 tables of frequencies. All multivariate logistic 
regression analysis was undertaken for all variables signifi-
cantly (P , 0.1) associated with the presence of renal calculi. 
Data were analyzed using the JMP program (SAS Institute, 
Cary, NC, USA)
Results
Of the 168 patients analyzed, 93 had Crohn’s disease and 
75 had ulcerative colitis. Table 1 outlines their baseline char-
acteristics, which are typical for the IBD population at this 
clinic. The mean age was 42 years, and females accounted 
for 52% of the patients with Crohn’s disease and 75% of 
those with ulcerative colitis. Overall, 16% of patients with 
ulcerative colitis had active disease at the time of enrollment, 
and the distribution of disease was as expected for IBD. Only 
two of the cohort, both with Crohn’s disease, had a history 
of prior ileal resection.
The prevalence of nephrolithiasis in the patients with 
Crohn’s disease was 38% compared with 38% for those with 
ulcerative colitis. The prevalence of hydronephrosis was 10% 
in the patients with Crohn’s disease and 13% in those with 
ulcerative colitis. Although none of the patients had been 
previously hospitalized for symptomatic nephrolithiasis, nine 
patients with Crohn’s disease and five with ulcerative colitis 
(the same patients who developed hydronephrosis) had a 
history of recurrent urinary tract infection.
The univariate factors associated with nephrolithiasis 
are detailed in Table 2. Nephrolithiasis was more prevalent 
in patients with ileocolonic (L3) disease than in those with 
other subtypes of Crohn’s disease, including ileal disease 
Table 1 Baseline characteristics of patients
Variable CD (n = 93) UC (n = 75)
Mean age (years) 41 43
Female (%) 52 75
Prior surgery (%) 2 0
Disease geography (%)
  Ileal disease 69 0
  Pancolitis 0 21
  Active at enrollment (%) 24 16
Current medications (%)
  Mesalazine 98 100
  Prednisone 50 47
  Thiopurine 42 37
  Anti-TNF 36 4
  Methotrexate 18 2
  Antibiotics 24 8
Abbreviations: CD, Crohn’s disease; UC, ulcerative colitis; TNF, tumor necrosis 
factor.
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only (odds ratio 2.3, P = 0.007). The numbers of patients with 
prior surgery (2%) was insufficient to draw conclusions about 
its association with formation of renal calculi in patients with 
Crohn’s disease. In patients with ulcerative colitis, extent of 
disease was not significantly associated with nephrolithiasis 
(P = 0.195). However, active ulcerative colitis represented 
a significant risk factor for formation of renal calculi (odds 
ratio 4.2, 95% confidence interval 1.1–15, P = 0.02). In all 
patients with IBD, any medication use was associated with 
renal calculi, although this association was not significant 
when controlled for disease activity.
Discussion
Inflammatory bowel disease is typically accompanied by diar-
rhea and malabsorption, both of which are predisposing fac-
tors for formation of renal calculi. The risk is increased when 
patients have previously undergone surgical procedures, such 
as total colectomy with ileostomy, small bowel resection, or 
intestinal bypass.5 Previous studies have reported that the 
prevalence of renal calculi is 7%–15% in patients with IBD,10 
but many of those studies involved populations in which the 
rates of intestinal resection were high. In patients with IBD 
(having previously undergone surgery or not), it is important 
that this complication be investigated in a timely manner in 
order to prevent chronic kidney disease, as demonstrated in 
previous studies.10,11 Ultrasound is highly effective in show-
ing large stones (.5 mm), and coupled with its safety relative 
to computed tomography, is the preferred screening method 
for renal calculi in asymptomatic populations.12,13
In this study, we demonstrated a high prevalence of 
asymptomatic renal calculi detected by ultrasound in a 
community-based population of patients with IBD. This rate 
is higher than that expected in the general population, as well 
as being higher that the approximately 7%–15% reported in 
patients with Crohn’s disease of the terminal ileum. There 
are few data regarding the mechanisms of nephrolithiasis in 
patients with IBD who have not undergone prior resection. 
A recent study conducted in Brazil by Pontes et al showed 
that patients with Crohn’s disease who had undergone sur-
gery were more likely to develop renal calculi than were 
those who had not, and that the incidence of calcium oxalate 
stones was higher in the former group, the difference being 
statistically significant.14 This study differed from ours, as 
the percentage of patients who had undergone prior surgery 
was 44.8%.12,14
Among patients with Crohn’s disease in our study, only 
ileocolonic disease, and not ileal disease in general, was a 
significant risk factor for renal calculi. These data clearly 
show that not only previous surgery but also the extent of 
disease contributes to nephrolithiasis, and that more extensive 
disease translates to more severe diarrhea. Therefore, patients 
with extensive disease should be investigated regardless of 
their surgical status.
Among the patients with ulcerative colitis and renal 
  calculi, females predominated (P = 0.012). We believe that 
this was due to the fact that more females than males   presented 
with active disease at the first medical appointment. Disease 
activity played an extremely important role in the   formation 
of renal calculi in patients with ulcerative colitis (odds 
ratio 4.2, 95% confidence interval 1.1–15, P = 0.02). This 
might have been due to the number of episodes of   diarrhea, 
which could have led to an increase in urinary   volume and 
greater urinary electrolyte loss due to   dehydration, a situation 
that is not uncommon in these patients.
The rates of renal calculi detected in the present study 
were higher than those described in the literature, even using 
an imaging modality that may miss stones ,5 mm in size. 
There are two possibilities that may explain this finding. 
First, prior studies in IBD did not screen for nephrolithiasis in 
asymptomatic populations, so the relative prevalence in this 
population is less well defined. Second, the patients all came 
from a region where cattle ranches are a dominant industry, so 
high meat consumption might have contributed to the results, 
given that high dietary protein intake has been associated with 
renal stone formation. However, it should be borne in mind 
that we did not investigate factors such as diet and body mass 
index. In addition, it should be taken into consideration that 
community-based centers such as our facility generally receive 
patients who have never received specialist care, so patients 
present with more extensive or more severe disease.
Table 2 Univariate factors associated with renal calculi
Variable CD (n = 93) UC (n = 75)
Disease activity (UC) – OR 4.2 (95% CI 
1.1–15, P = 0.02)
Disease location (L3) OR 2.3 (95% CI  
1.8–7, P = 0.007)
–
Steroids – OR 2.9 (95% CI 
1.1–7, P = 0.03)
Ciprofloxacin OR 5.2 (95% CI  
1.9–14, P = 0.002)
OR 10 (95% CI 
1.1–90, P = 0.03)
Immunomodulator OR 4.2 (1.7–10,  
P = 0.001)
OR 3.9 (95% CI  
1.4–10, P = 0.006)
Metronidazole OR 3.5 (95% CI  
1.3–9.8, P = 0.002)
OR 12 (95% CI 
1.5–110, P = 0.01)
Methotrexate OR 3.8 (95% CI  
1.3–11, P = 0.01)
–
Abbreviations:  CD,  Crohn’s  disease;  UC,  ulcerative  colitis;  OR,  odds  ratio;   
CI, confidence interval.




Nephrolithiasis in patients with inflammatory bowel diseaseInternational Journal of Nephrology and Renovascular Disease
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journal
The International Journal of Nephrology and Renovascular Disease is 
an international, peer-reviewed open-access journal focusing on the 
pathophysiology of the kidney and vascular supply. Epidemiology, screen-
ing, diagnosis, and treatment interventions are covered as well as basic 
science, biochemical and immunological studies. The journal welcomes 
original research, clinical studies, reviews & evaluations, expert opinion and 
commentary, case reports and extended reports. The manuscript manage-
ment system is completely online and includes a very quick and fair peer-
review system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nephrology and Renovascular Disease 2013:6
The limitations of this study include a small population 
size, not being powered for small differences, few patients 
who had surgery, no evaluation of stone composition or renal 
function, and selection bias in referral practice. Strengths 
include it being a community-based cohort with prospective 
enrollment and a well characterized population.
The results of the present study highlight the prevalence 
of nephrolithiasis in patients with Crohn’s disease or ulcer-
ative colitis, regardless of their surgical status. Specialists 
should consider this diagnosis in patients with unexplained 
renal dysfunction, abdominal pain, or recurrent urinary tract 
infection, and should adopt a multidisciplinary approach in 
these patients in order to prevent complications.
Disclosure
The authors report no conflicts of interest in this work.
References
1.  Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time 
trends in reported prevalence of kidney stones in the United States: 
1976–1994. Kidney Int. 2003;63(5):1817–11823.
2.  Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study 
of dietary calcium and other nutrients and the risk of symptomatic kidney 
stones. N Engl J Med. 1993;328(12):833–838.
3.  Clark JY, Thompson IM, Optenberg SA. Economic impact of urolithiasis 
in the United States. J Urol. 1995;154(6):2020–2024.
  4.  Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and 
the risk of incident kidney stones in younger women: Nurses’ Health 
Study II. Arch Intern Med. 2004;164(8):885–891.
  5.  Parks JH, Worcester EM, O’Connor RC, Coe FL. Urine stone risk fac-
tors in nephrolithiasis patients with and without bowel disease. Kidney 
Int. 2003;63(1):255–265.
  6.  Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes 
and consequences of kidney loss in patients with nephrolithiasis. Kidney 
Int. 2003;64(6):2204–2213.
  7.  Kumar R, Ghoshal UC, Singh G, Mittal RD. Infrequency of coloni-
zation with Oxalobacter formigenes in inflammatory bowel disease: 
possible role in renal stone formation. J Gastroenterol Hepatol. 
2004;19(12):1403–1409.
  8.  Bansal AD, Hui J, Goldfarb DS. Asymptomatic nephrolithiasis detected 
by ultrasound. Clin J Am Soc Nephrol. 2009;4(3):680–684.
  9.  Van Assche G, Vermeire S, Rutgeerts P. The potential for disease 
modification in Crohn’s disease. Nat Rev Gastroenterol Hepatol. 
2010;7(2):79–85.
  10.  Andersson  H,  Bosaeus  I,  Fasth  S,  Hellberg  R,  Hulten  L.   
Cholelithiasis and urolithiasis in Crohn’s disease. Scand  J   
Gastroenterol. 1987;22(2):253–256.
  11.  Cirillo M, Iudici M, Marcarelli F, Laudato M, Zincone F. Nephrolithiasis 
in patients with intestinal diseases. G Ital Nefrol. 2008;25(1):42–48. 
Italian.
  12.  Jin DH, Lamberton GR, Broome DR, et al. Effect of reduced 
radiation CT protocols on the detection of renal calculi. Radiology. 
2010;255(1):100–107.
  13.  Mugiya S. Guidelines on urolithiasis: update of diagnosis and   treatment. 
Hinyokika Kiyo. 2012;58(12):703–706. Japanese.
  14.  Viana ML, Pontes RM, Garcia WE, Favero ME, Prete DC, Matsuo T. 
Crohn’s disease and kidney stones: much more than coincidence? Arq 
Gastroenterol. 2007;44(3):210–214.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
142
Cury et al